2012 will be a year rich in investments for Sunstone Capital. Whereas the company only invested in two new companies within life science in 2011, that number is expected to rise to between 4 and 6 investments in the current year.
“We have made our first investment in Galecto, and we will make at least one more, possibly two, by this summer. So my hope is that we will have three investments in new companies at the close of the first six months. We plan to carry out as many as that in the fall as well. So we are going to be very active on the market this year,” says Peter Benson, managing partner in Sunstone Capital.